Stock Analysis
- China
- /
- Medical Equipment
- /
- SHSE:688067
AVE Science&TechnologyLTD Full Year 2023 Earnings: EPS: CN¥0.32 (vs CN¥0.26 in FY 2022)
AVE Science&TechnologyLTD (SHSE:688067) Full Year 2023 Results
Key Financial Results
- Revenue: CN¥200.3m (up 1.8% from FY 2022).
- Net income: CN¥21.5m (up 20% from FY 2022).
- Profit margin: 11% (up from 9.1% in FY 2022).
- EPS: CN¥0.32 (up from CN¥0.26 in FY 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
AVE Science&TechnologyLTD shares are up 8.9% from a week ago.
Risk Analysis
We should say that we've discovered 2 warning signs for AVE Science&TechnologyLTD (1 is a bit concerning!) that you should be aware of before investing here.
Valuation is complex, but we're helping make it simple.
Find out whether AVE Science&TechnologyLTD is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SHSE:688067
AVE Science&TechnologyLTD
AVE Science&Technology CO.,LTD researches, develops, manufactures, markets, and services medical devices, biological reagents, remote medical diagnosis network, computer software, automatic control devices, and medical auxiliary equipment.
Flawless balance sheet with proven track record.